North America Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Country and Growth Forecast, 2023 - 2030
Description
North America Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component (Neurorehabilitation Therapy, and Neurocognitive Assessment Testing), By Providers, By Country and Growth Forecast, 2023 - 2030
The North America Neurocognitive Assessment And Rehabilitation Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).
Neurocognitive assessment systematically evaluates an individual's cognitive functions, including memory, attention, language, executive functions, and sensory-perceptual abilities. This process involves a battery of standardized tests and tools designed to measure cognitive performance and identify deviations from the norm. Assessment tools may range from traditional paper-and-pencil tests to cutting-edge neuroimaging techniques, providing a comprehensive picture of an individual's cognitive health. On the other hand, neurocognitive rehabilitation involves therapeutic interventions to improve or restore cognitive functions that have been compromised due to neurological conditions, injuries, or age-related factors.
Moreover, the market is evolving, propelled by advancements in neuroscience, technology, and an increasing awareness of neurological disorders. This burgeoning field focuses on understanding and addressing cognitive impairments through a multidisciplinary approach, encompassing assessments, interventions, and rehabilitation strategies. As they delve into this dynamic landscape, it becomes evident that the intersection of neuroscience and technology unlocks unprecedented opportunities to enhance the understanding of the brain, diagnose cognitive disorders, and implement effective rehabilitation techniques.
The Centers for Disease Control and Prevention estimate that more than one in every seven adults in the United States has CKD, or approximately 35.5 million individuals, or 14%. People aged 65 or older have a higher prevalence of CKD (34%) compared to those aged 45–64 (12%) or 18–44 (6%). Early identification enables timely intervention and the implementation of strategies to address cognitive deficits before they significantly impact daily functioning. As a result, these aspects will boost market growth in the coming years.
The US market dominated the North America Neurocognitive Assessment And Rehabilitation Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,691.8 Million by 2030. The Canada market is experiencing a CAGR of 10.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.1% during (2023 - 2030).
Based on Component, the market is segmented into Neurorehabilitation Therapy, and Neurocognitive Assessment Testing. Based on Providers, the market is segmented into Rehab Centers, Hospital & Clinics, Homecare Settings, and Physiotherapy Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health, NeuronUP SL and SCHUHFRIED GmbH
Scope of the Study
Market Segments covered in the Report:
By Component
- Neurorehabilitation Therapy
- Neurocognitive Assessment Testing
- Rehab Centers
- Hospital & Clinics
- Homecare Settings
- Physiotherapy Centers
- US
- Canada
- Mexico
- Rest of North America
- Cambridge Cognition Holdings plc
- Cognifit, Inc.
- Cogstate Ltd.
- Lumos Labs, Inc. (Lumosity)
- CNS Vital Signs, LLC
- Posit Science Corporation
- BrainCheck, Inc.
- Constant Therapy Health
- NeuronUP SL
- SCHUHFRIED GmbH
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
89 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Neurocognitive Assessment And Rehabilitation Market, by Component
- 1.4.2 North America Neurocognitive Assessment And Rehabilitation Market, by Providers
- 1.4.3 North America Neurocognitive Assessment And Rehabilitation Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. North America Neurocognitive Assessment And Rehabilitation Market by Component
- 4.1 North America Neurorehabilitation Therapy Market by Country
- 4.2 North America Neurocognitive Assessment Testing Market by Country
- Chapter 5. North America Neurocognitive Assessment And Rehabilitation Market by Providers
- 5.1 North America Rehab Centers Market by Country
- 5.2 North America Hospital & Clinics Market by Country
- 5.3 North America Homecare Settings Market by Country
- 5.4 North America Physiotherapy Centers Market by Country
- Chapter 6. North America Neurocognitive Assessment And Rehabilitation Market by Country
- 6.1 US Neurocognitive Assessment And Rehabilitation Market
- 6.1.1 US Neurocognitive Assessment And Rehabilitation Market by Component
- 6.1.2 US Neurocognitive Assessment And Rehabilitation Market by Providers
- 6.2 Canada Neurocognitive Assessment And Rehabilitation Market
- 6.2.1 Canada Neurocognitive Assessment And Rehabilitation Market by Component
- 6.2.2 Canada Neurocognitive Assessment And Rehabilitation Market by Providers
- 6.3 Mexico Neurocognitive Assessment And Rehabilitation Market
- 6.3.1 Mexico Neurocognitive Assessment And Rehabilitation Market by Component
- 6.3.2 Mexico Neurocognitive Assessment And Rehabilitation Market by Providers
- 6.4 Rest of North America Neurocognitive Assessment And Rehabilitation Market
- 6.4.1 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Component
- 6.4.2 Rest of North America Neurocognitive Assessment And Rehabilitation Market by Providers
- Chapter 7. Company Profiles
- 7.1 Cambridge Cognition Holdings PLC
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Partnerships, Collaborations, and Agreements:
- 7.1.5.2 Product Launches and Product Expansions:
- 7.1.5.3 Acquisition and Mergers:
- 7.1.6 SWOT Analysis
- 7.2 Cognifit, Inc.
- 7.2.1 Company Overview
- 7.3 Cogstate Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 SWOT Analysis
- 7.4 Lumos Labs, Inc. (Lumosity)
- 7.4.1 Company Overview
- 7.4.2 SWOT Analysis
- 7.5 CNS Vital Signs, LLC
- 7.5.1 Company Overview
- 7.5.2 SWOT Analysis
- 7.6 Posit Science Corporation
- 7.6.1 Company Overview
- 7.6.2 SWOT Analysis
- 7.7 BrainCheck, Inc.
- 7.7.1 Company Overview
- 7.7.2 SWOT Analysis
- 7.8 Constant Therapy Health
- 7.8.1 Company Overview
- 7.8.2 Recent strategies and developments:
- 7.8.2.1 Trials and Approvals:
- 7.8.3 SWOT Analysis
- 7.9 NeuronUP SL
- 7.9.1 Company Overview
- 7.9.2 SWOT Analysis
- 7.10. SCHUHFRIED GmbH
- 7.10.1 Company Overview
- 7.10.2 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
